Cystic fibrosis: Evidence for gut inflammation

International Journal of Biochemistry and Cell Biology

Volumn 52, Issue , 2014, Pages 180-183

  Munck, Anne ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Cystic fibrosis; Gut; Immune response; Inflammation

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; ALBUMIN; ANTIBIOTIC AGENT; BICARBONATE; CALGRANULIN; CHLORIDE CHANNEL; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ELECTROLYTE; EOSINOPHIL CATIONIC PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 8; LEUKOCYTE ELASTASE; LEUKOTRIENE B4; LUBIPROSTONE; OXIDOREDUCTASE; PHOSPHOLIPASE A2; PROBIOTIC AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; RNA 16S; SODIUM CHLORIDE;

ARTICLE; BACTERIAL OVERGROWTH; BIFIDOBACTERIUM; CHRONIC INFLAMMATION; CLOSTRIDIUM; CYSTIC FIBROSIS; DIGESTION; DISEASE ASSOCIATION; DOWN REGULATION; DYSBIOSIS; ELECTROLYTE TRANSPORT; ELEMENTAL DIET; ENTERITIS; ENZYME ACTIVITY; FECES MICROFLORA; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; ICOSANOID METABOLISM; INNATE IMMUNITY; INTESTINE ABSORPTION; INTESTINE FLORA; INTESTINE FUNCTION DISORDER; INTESTINE MOTILITY; INTESTINE OBSTRUCTION; INTESTINE TRANSIT TIME; LACTOBACILLUS CASEI; MAST CELL; MOUSE MODEL; MUCUS SECRETION; NEUTROPHIL; NONHUMAN; PANCREAS; PATHOGENESIS; PATHOPHYSIOLOGY; PNEUMONIA; SOLUBILITY; STOMACH PH; UPREGULATION; ANIMAL; DISEASE MODEL; GASTROENTERITIS; METABOLISM; MOUSE; PATHOLOGY;

BACTERIA (MICROORGANISMS);

ANIMALS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; GASTROENTERITIS; HUMANS; MICE;

EID: 84901625117     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2014.02.005     Document Type: Article

References (33)

1. T.V. Strong, K. Boehm, and F.S. Collins Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization J Clin Invest 93 1 1994 347 354 (Pubitemid 24030855)
2. V.A. Stallings Clinical Practice Guidelines on Growth and Nutrition Subcommittee; Ad Hoc Working Group Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review J Am Diet Assoc 108 5 2008 832 839 [Review] (Pubitemid 351602057)
3. R.C. De Lisle et al. Changes in the exocrine pancreas secondary to altered small intestinal function in the CF mouse Am J Physiol Gastrointest Liver Physiol 281 4 2001 899 906
4. C. Guilbault et al. Cystic fibrosis mouse models Am J Respir Cell Mol Biol 36 1 2007 1 7 [Review] (Pubitemid 46067701)
5. R.C. De Lisle, and D. Borowitz The cystic fibrosis intestine Cold Spring Harb Perspect Med 3 September (9) 2013 a009753 10.1101/cshperspect.a009753
6. E.K. Malmberg et al. Increased levels of mucins in the cystic fibrosis mouse small intestine, and modulator effects of the Muc1 mucin expression Am J Physiol Gastrointest Liver Physiol 291 2 2006 203 210
7. R.C. De Lisle, R. Sewell, and L. Meldi Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine Neurogastroenterol Motil 22 3 2010 341 387
8. R.C. De Lisle et al. Altered eicosanoid metabolism in the cystic fibrosis mouse small intestine J Pediatr Gastroenterol Nutr 47 4 2008 406 416
9. O. Norkina, T.G. Burnett, and R.C. De Lisle Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine Infect Immun 72 10 2004 6040 6049 (Pubitemid 39303719)
10. R.C. De Lisle Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine Am J Physiol Gastrointest Liver Physiol 293 1 2007 G104 G111
11. S.V. Lynch et al. Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota Gut Microbes 4 1 2013 41 47
12. J.C. Canale-Zambrano, M.L. Auger, and C.K. Haston Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice Am J Physiol Gastrointest Liver Physiol 299 2 2010 G381 G390
13. H. Yu, S.Z. Nasr, and V. Deretic Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis Infect Immun 68 4 2000 2142 2147 (Pubitemid 30164847)
14. O. Norkina et al. Inflammatin of the cystic fibrosis mouse small intestine Am J Physiol Gastrointest Liver Physiol 286 2004 G1032 G1041
15. L.C. Yu, and M.H. Perdue Role of mast cells in intestinal mucosal function: studies in models of hypersensitivity and stress Immunol Rev 179 2001 61 73 [Review] (Pubitemid 32171274)
16. -/- mice J Cell Physiol 200 2 2004 235 244 (Pubitemid 38880207)
17. V. Raia et al. Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients Pediatr Res 47 3 2000 344 350 (Pubitemid 30127040)
18. R.L. Smyth et al. Intestinal inflammation in cystic fibrosis Arch Dis Child 82 5 2000 394 399 (Pubitemid 30307771)
19. G. Duytschaever et al. Cross-sectional and longitudinal comparison of the predominant fecal microbiota composition between a group of pediatric patients with cystic fibrosis and their healthy siblings Appl Environ Microbiol 77 2011 8015 8024
20. G. Duytschaever et al. Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota J Cyst Fibros 12 3 2013 206 215
21. S.L. Werlin et al. Evidence of intestinal inflammation in patients with cystic fibrosis J Pediatr Gastroenterol Nutr 51 3 2010 304 308
22. J.M. Lee et al. Update of faecal markers of inflammation in children with cystic fibrosis Mediators Inflamm 2012 2012 948367
23. E. Bruzzese et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration Aliment Pharmacol Ther 20 7 2004 813 819 (Pubitemid 39319237)
24. R.C. De Lisle, E.A. Roach, and O. Norkina Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation J Pediatr Gastroenterol Nutr 42 1 2006 46 52 (Pubitemid 43061009)
25. L.L. Clarke et al. Increased survival of CFTR knockout mice with an oral osmotic laxative Lab Anim Sci 46 6 1996 612 618
26. R.C. De Lisle, E. Roach, and K. Jansson Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine Am J Physiol Gastrointest Liver Physiol 293 3 2007 G577 G584
27. J. Cuppoletti et al. SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents Am J Physiol Cell Physiol 287 5 2004 C1173 C1183
28. R.C. De Lisle, R. Mueller, and E. Roach Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype BMC Gastroenterol 10 2010 107
29. - secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator Gastroenterology 137 3 2009 976 985
30. E. Bruzzese et al. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study Clin Nutr 26 3 2007 322 328 (Pubitemid 46760477)
31. B. Weiss et al. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study Pediatr Pulmonol 45 6 2010 536 540
32. S. Freedman, and C.R. Martin Pediatr Pulmonol 36 Suppl. 2013 S125 S126
33. T. Strowig et al. Inflammasomes in health and disease Nature 481 7381 2012 278 286